Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Shenzhen Fuwo Pharmaceutical

Request full access

Pioneering small molecule drugs for NSCLC with EGFR exon20 insertion mutations

Ningbo, ChinaFounded 2015Biotech & Life Sciences

About Shenzhen Fuwo Pharmaceutical

Forward Pharm is focused on the clinical development of FWD1509, a novel small molecule drug targeting non-small cell lung cancer (NSCLC) with EGFR exon20 insertion mutations. This innovative approach addresses a significant unmet need, as current treatments for this specific mutation are limited in efficacy. The company operates within the pharmaceutical and biotechnology sectors, primarily serving patients with NSCLC. Forward Pharm's business model involves drug research and development, leveraging strategic partnerships, such as its collaboration with WuXi AppTec Group, to advance its clinical trials and regulatory submissions. Revenue generation is anticipated through successful drug development and eventual market approval. The company has secured angel and Pre-A round financing to support its operations and growth. Forward Pharm is a key player in the Guangdong Manufacturing Innovation Center, contributing to the advancement of small molecule drug innovation.

Source: Dealroom company data

At a glance

Status
Operational
Open positions
None listed
Dealroom signal
21.0/100
Industry
Health
Sub-industry
BioTechnology
Sector
Biotechnology, Spinout, Biotech and Pharma, DT and LS, science-based
Business model
Manufacturing
Client focus
B2B
Links
Website

Funding history

4 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES B✓Equity / VC Mar 2026 — — Wuhan S&T Investment Company ↗
SERIES B✓Equity / VC Mar 2025 $14M $55M Wuhan Hi-Tech State-owned Holding ↗
Showing the latest 2 of 4 recorded eventsBook a demo for the full funding history →

Growth signals

Shenzhen Fuwo Pharmaceutical website traffic

Latest recorded traffic for Shenzhen Fuwo Pharmaceutical is 1.8K monthly website visits, up 63.6% over the last three months.

Latest monthly visits1.8K 3-month web change+63.6%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Shenzhen Fuwo Pharmaceutical in the Ningbo ecosystem

Live from Dealroom

The Shenzhen Fuwo Pharmaceutical office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

4 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A3 investors entered at this stage

  • Zhongguancun Development Qihang Industrial Investment Fund
  • Wuhan Hi-Tech State-owned Holding
  • Wuhan S&T Investment Company

Other known investors1 additional known investor

  • Shenzhen Tsinghua University Research Institute
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇨🇳 China · Ningbo HQ
Book a demo for the full country breakdown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Shenzhen Fuwo Pharmaceutical on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Shenzhen Fuwo Pharmaceutical’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.